USFDA Approves Glenmark’s Generic Formulation for Schizophrenia Treatment

USFDA Approves Glenmark's Generic Formulation for Schizophrenia Treatment

November 7, 2023 : Glenmark Pharmaceuticals, a leading global generics, and specialty pharmaceutical company, has received final approval from the United States Food and Drug Administration (USFDA) for its generic formulation of Chlorpromazine Hydrochloride Tablets USP, in the strengths of 10 mg, 25 mg, and 50 mg, 100 mg, and 200 mg.

UKHSA Launches Vivaldi Social Care Pilot

UKHSA Launches Vivaldi Social Care Pilot

November 3, 2023 : The United Kingdom Health Security Agency (UKHSA) has announced the launch of the Vivaldi social care pilot, a new initiative to improve the quality of care for people living in social care settings.

Devastating Bird Flu Officially Reaches Antarctica for the First Time

Devastating Bird Flu Officially Reaches Antarctica for the First Time

October 24, 2023 : Highly pathogenic avian influenza (HPAI), also known as bird flu, has officially reached Antarctica for the first time. The virus was detected in brown skua (Catharacta antarctica) carcasses on Bird Island, a subantarctic island north of the Antarctic Peninsula.

Berlin-based Lillian Care Closes €2.4M to Tackle Shortage of Doctors

Berlin-based Lillian Care Closes €2.4M to Tackle Shortage of Doctors

October 23, 2023 : Lillian Care, a Berlin-based healthcare technology startup, has closed a €2.4M pre-seed funding round. The funding will be used to establish hybrid medical practices nationwide and to address the shortage of general practitioners (GPs) in underserved areas of Germany.